Publications — Radcliffe Department of Medicine

Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Is Risk-Stratifying Patients with Colorectal Cancer Using a Deep Learning-Based Prognostic Biomarker Cost-Effective?

Kenseth A. et al, (2024), Pharmacoeconomics, 42, 679 - 691

Unification of Efforts to Improve Global Access to Cancer Therapeutics: Report From the 2022/2023 Access to Essential Cancer Medicines Stakeholder Summit.

Briercheck E. et al, (2024), JCO Glob Oncol, 10

Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes.

Chen Z. et al, (2024), Nat Commun, 15

An Explainable Coarse-to-Fine Survival Analysis Method on Multi-Center Whole Slide Images

Wang H. et al, (2024), IEEE Transactions on Artificial Intelligence, 5, 1316 - 1327

Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.

Frei AL. et al, (2024), Lancet Oncol, 25, 198 - 211

Dihydropyrimidine dehydrogenase gene variants for predicting grade 4-5 fluoropyrimidine-induced toxicity: FUSAFE individual patient data meta-analysis.

Le Teuff G. et al, (2024), Br J Cancer

Guidelines for study protocols describing predefined validations of prediction models in medical deep learning and beyond

Kleppe A. et al, (2024), Nature Machine Intelligence, 6, 2 - 3

Personalizing adjuvant therapy for patients with colorectal cancer.

Yang L. et al, (2023), Nat Rev Clin Oncol

Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.

Frei AL. et al, (2023), J Pathol Clin Res, 9, 449 - 463

Data from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

Data from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

Supplementary Data from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

Supplementary Data from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

Supplementary Figures from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

Supplementary Figures from GTP Cyclohydrolase Drives Breast Cancer Development and Promotes EMT in an Enzyme-Independent Manner

Wang Z. et al, (2023)

GTP cyclohydrolase drives breast cancer development and promotes EMT in an enzyme-independent manner.

Wang Z. et al, (2023), Cancer Res

Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance.

Wiley MB. et al, (2023), Cancers (Basel), 15

Author Correction: Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries.

Fernandez-Rozadilla C. et al, (2023), Nat Genet

Bestrophin-4 relays Hes4 and interacts with Twist1 to suppress epithelial-to-mesenchymal transition in colorectal cancer cells

Wang Z. et al, (2023)

Cancer Pathogenesis and Therapy: A new journal, a new inspiration

Shi Y. and Kerr DJ., (2023), Cancer Pathogenesis and Therapy, 1, 1 - 2

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?